Literature DB >> 26707878

Nanog interact with CDK6 to regulates astrocyte cells proliferation following spinal cord injury.

Jun Gu1, Yingjie Ni2, Lin Xu2, Hongliang Xu2, Zhengdong Cai3.   

Abstract

Previous research had reported transcription factors Nanog expressed in pluripotent embryonic stem cells (ESCS) that played an important role in regulating the cell proliferation. Nanog levels are frequently elevated in ESCS, but the role in the spinal cord was not clear. To examine the biological relevance of Nanog, we studied its properties in spinal cord injury model. The expression of Nanog and PCNA was gradually increased and reached a peak at 3 day by western blot analysis. The expression of Nanog was further analyzed by immunohistochemistry. Double immunofluorescent staining uncovered that Nanog can co-labeled with PCNA and GFAP in the spinal cord tissue. In vitro, Nanog can promote the proliferation of astrocyte cell by Fluorescence Activating Cell Sorter (FACS) and CCK8. Meanwhile, the cell-cycle protein CDK6 could interact with Nanog in the spinal cord tissue. Taken together, these data suggested that both Nanog may play important roles in spinal cord pathophysiology via interact with CDK6.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Astrocyte; CDK6; Nanog; Proliferation; Spinal cord

Mesh:

Substances:

Year:  2015        PMID: 26707878     DOI: 10.1016/j.bbrc.2015.12.053

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Expression of TAS2R14 in the intestinal endocrine cells of non-human primates.

Authors:  Misa Hayashi; Akihiko Inaba; Miho Hakukawa; Ken Iwatsuki; Hiroo Imai; Katsuyoshi Masuda
Journal:  Genes Genomics       Date:  2021-02-20       Impact factor: 1.839

2.  Sleep Deprivation Induces Cognitive Impairment by Increasing Blood-Brain Barrier Permeability via CD44.

Authors:  Jing Sun; Jusheng Wu; Fuzhou Hua; Yong Chen; Fenfang Zhan; Guohai Xu
Journal:  Front Neurol       Date:  2020-11-27       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.